Editorial: Role of the IL-23/IL-17 Pathway in Chronic Immune-Mediated Inflammatory Diseases: Mechanisms and Targeted Therapies
Main Authors: | Elisabetta Bianchi, Matteo Vecellio, Lars Rogge |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.770275/full |
Similar Items
-
The Role of the IL-23/IL-17 Pathway in the Pathogenesis of Spondyloarthritis
by: Hiroyuki Tsukazaki, et al.
Published: (2020-09-01) -
IL-23 Inhibition in Ankylosing Spondylitis: Where Did It Go Wrong?
by: Dominique Baeten, et al.
Published: (2021-02-01) -
Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints
by: Marie-Astrid Boutet, et al.
Published: (2018-02-01) -
Expressions of IL-17, IL-21 and IL-23 in the serum of allergic rhinitis patients
by: Huang Xuekun, et al.
Published: (2011-01-01) -
Whodunit? The Contribution of Interleukin (IL)-17/IL-22-Producing γδ T Cells, αβ T Cells, and Innate Lymphoid Cells to the Pathogenesis of Spondyloarthritis
by: Annika Reinhardt, et al.
Published: (2018-04-01)